Tag Archives: cure

Latest: Germany saw 7,000 new infections for the first time | Instant News


BERLIN – Germany has confirmed more than 7,000 new coronavirus infections for the first time, a second consecutive daily record.

The Robert Koch Institute, Germany’s national center for disease control, said Friday morning that 7,334 new cases were confirmed in the preceding 24 hours. That compared to 6,638 the day before.

As of this week, Germany’s highest figure was recorded at nearly 6,300 at the end of March, although testing has grown rapidly since then. The figures are likely to peak around the end of the week, but the latest reading underscores the sharp upward trend in recent weeks.

Earlier this week, the federal and state governments agreed to tighten rules on wearing masks and early closing bars in areas where infections are high.

Germany has confirmed a total of more than 348,000 cases since the pandemic began, including 9,734 deaths – an increase of 24 compared with Thursday.

HERE WHAT YOU NEED TO KNOW ABOUT THE OUTBREAK VIRUS:

– Europe, the US reel as viral infections soaring at high speed, immediately implement new restrictions

– The White House locates political operations at the CDC to try to control virus information

– Thousand arrived in Hawaii on the first day of pre-travel testing that did not allow quarantine

———

– Follow AP pandemic coverage on http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak

———

HERE WHAT ELSE HAPPENED:

MILAN – The Campania region in Italy, which includes Naples, is closing schools until the end of the month as the number of infections there jumps above 1,000.

Italian health officials have declared the country in an “acute phase” after it recorded a new daily case record higher than during the March-April peak, when the death toll jumped by more than 900 in a single 24-hour period.

Thursday’s death toll rose to 83, a third of those in Lombardy, after days of reaching half nationwide.

Prime Minister Giuseppe Conte expressed his displeasure at Campania’s decision to close the school, which opened only a month ago.

However, other areas have urged the government to allow distance learning for the upper classes of middle school to reduce public transport pressure which remains a major concern due to overcrowding.

———

LONDON – A top UK scientist says the continuing argument about how and when to impose stricter restrictions to fight COVID-19 is damaging public health and causing more economic hardship.

An infectious disease specialist who sits on the government’s scientific advisory committee said the UK needed to immediately implement stricter restrictions nationally to slow the spread of the virus and limit wider damage to society.

Jeremy Farrar, director of research funding charity Wellcome Trust, said the restrictions under the government’s current three-tier strategy are not harsh enough to contain the virus and debate where and when to enact measures risks confusing the public.

“I think we have to unite as a country,” Farrar told the BBC’s Newscast podcast. “Divisions and, to be honest, make this a matter of north-south politics or the party which is a very, very dangerous road to go on.”

———

PRAGUE – Coronavirus infections in the Czech Republic have set a new one-day record for the second day in a row.

Health Ministry figures showed the daily increase of 9,721 on Thursday, 177 more than the previous record set the day before.

The country of more than 10 million has had a total of 149,010 cases since the start of the pandemic. Nearly 50,000 of them have registered last week. It has also seen 1,230 deaths.

Hospitals across the country have postponed planned nonvital operations to focus on increasing the number of COVID-19 patients. The government said their full capacity could be reached around the end of October.

The Czech military will start building a field hospital in the Prague exhibition center at the weekend for 500 patients. Similar plans have been put in place for the second largest city in Brno, while the government is negotiating with neighboring Germany and several other countries to have the Czechs treated there if the local health system becomes overwhelmed.

———

WINDOW ROCK, Ariz. – Navajo Nation health officials on Thursday reported 31 new confirmed cases of COVID-19, but no deaths for two straight days.

The latest figures bring the total number of cases to 10,819. The known death toll remains at 571.

Tribal health officials say 114,515 people on the sprawling reservation covering parts of Arizona, New Mexico and Utah have been tested for COVID-19 since the pandemic began.

On-site protection orders, mask mandates, daily curfews and weekend closings remain in effect in the Navajo Nation.

———

BEIJING – Authorities say they have completed coronavirus tests on more than 10 million people in the northern Chinese port city of Qingdao following an outbreak of a hospital there blamed for “improper disinfection”.

Testing is set to continue to cover 11 million people.

Authorities say a total of 13 cases have been found in the city, but not since a mass testing program was launched earlier this week.

Health officials said the infection cluster, the first reported case of localized transmission in China in about two months, appeared to be linked to “improper disinfection” in the CT room at Qingdao Chest Hospital. Officials said the possibility of community transmission outside the hospital had been ruled out.

The National Health Commission on Friday reported 24 new cases, all imported.

Chinese hospitals are currently treating 253 people for COVID-19, with another 381 people being monitored in isolation because they have tested positive for the virus without showing symptoms or as suspected cases.

———

NEW DELHI – Deaths from India’s new coronavirus surged to 895 in the past 24 hours, a day after recording a low of 680 daily deaths in nearly three months.

The Ministry of Health on Friday also reported 63,371 new cases, increasing India’s total since the pandemic started to more than 7.3 million.

According to the Health Ministry, India’s average daily number of cases fell to 72,576 last week from 92,830 during the week of September 9-15, when the virus peaked. It recorded an average of about 70,000 cases each day throughout this month.

Health officials have warned about the potential spread of the virus during the religious festival season which starts later this month.

———

COLOMBO, Sri Lanka – Sri Lankan authorities have ordered the closure of all cinemas in a bid to contain the outbreak that has infected 1,791 people on the outskirts of the capital so far.

The cluster at a garment factory in a densely populated Western province was discovered last week, and is the first in more than two months.

Authorities have also tightened curfews in parts of the country.

Apart from those infected, more than 2,000 others were asked to be quarantined at home. The majority of those infected were co-workers of the first patient.

Schools and main public offices were also closed, public gatherings banned and restrictions imposed on public transportation.

Sri Lanka has reported a total of 5,170 confirmed cases with 13 deaths since the pandemic began.

———

SEOUL, South Korea – South Korea’s coronavirus daily tally fell below 50 for the first time in more than two weeks despite reports of small-scale local infections.

The Korea Disease Control and Prevention Agency on Friday said the 47 cases added in the past 24 hours brought the country’s total to 25,035 with 441 deaths.

This is a decrease from the 110 reported a day earlier, about half of whom were tied to a hospital for the elderly in the southeastern city of Busan.

Health official Son Youngrae said South Korea’s caseload is currently showing a downward trend. But he said the public should remain vigilant as cluster infections have also been detected sporadically in hospitals and other high-risk facilities.

Earlier this week, South Korea relaxed its social distancing rules, allowing high-risk venues such as nightclubs and karaoke bars to reopen and spectators to return to sports stadiums.

———

SALEM, Ore. – Coronavirus cases in Oregon continue to increase.

State health officials announced 374 new and suspected COVID-19 cases on Thursday and three additional deaths from the pandemic.

The figure brings the state’s case tally since the pandemic starting to 38,525 infections and 611 deaths, according to the Oregon Health Authority.

Officials also reported 21 cases of outbreak Thursday in Georgia Pacific in Linn County, a company that makes tissue, packaging and building products.

———

SYDNEY – Australia’s largest city, Sydney, lifted quarantine restrictions for travelers from New Zealand on Friday, while the second largest city, Melbourne, marked the 100th day of one of the world’s longest pandemic lockdowns.

More than 350 passengers are scheduled to take three flights from Auckland on Friday and will not need to undergo hotel quarantine upon arrival in Sydney.

New South Wales state Prime Minister Gladys Berejiklian said: “This is great news for tourism. This is also great news for grateful family and business reunification. “

New Zealand will continue to urge travelers from Australia to quarantine their hotels for 14 days upon arrival.

The Victorian state government has resisted pressure from businesses and the federal government to ease a second lockdown that began when stay-at-home orders went into effect in Melbourne on July 9.

Victoria recorded only two new cases of COVID-19 in the past 24 hour period. The state last posted such a low number on June 8, with the daily tally peaking at 725 on August 5.

.



image source

Britain secures 90 million doses of potential coronavirus vaccine | Instant News


Britain will receive 90 million doses of a possible coronavirus vaccine after the government signs two agreements.

The Ministry of Business announced that it has an agreement with the French group Valneva and an alliance between the company Pfizer Inc. and BioNTech.

The deal with Pfizer-BioNTech will give Britain 30 million doses.

Another 60 million will be provided by Valneva, with the option of another 40 million doses if proven safe, effective and suitable, the ministry said.

“This new partnership with some of the world’s leading pharmaceutical and vaccine companies will ensure the UK has the best chance of getting a vaccine that protects those most at risk,” Business Minister Alok Sharma said.

The agreement follows an agreement previously announced with AstraZeneca to produce 100 million doses of a potential vaccine developed in partnership with the University of Oxford.

The British government also said it had received treatment containing COVID-19 antibody antibodies from AstraZeneca to protect people who cannot be vaccinated.

At present there is no vaccine that works against the corona virus and experts say one will be needed to control a pandemic that has infected millions of people worldwide and killed more than 600,000 people.

Progress was made to find a vaccine

Last week, human traces began for other potential vaccines in Queensland.

In Brisbane, 120 volunteers have received their first dose of potential immunization, developed by the University of Queensland (UQ).

This is one of several clinical trials being carried out across the country, including one that involves Queensland researchers and volunteers.

The trial, in which people will be injected with two doses every four weeks, will examine the safety and immune response of the vaccine among volunteers.

Preliminary results from the trial are expected to be released at the end of September.

Space to play or pause, M to mute, left and right arrows to search, up and down arrows for volume.
The US health director said “one or two” vaccine candidates could be ready by the end of the year.

In the United States, the country’s top infectious disease expert said he believed the vaccine could be found by the end of the year.

“There are several candidates, who are in various stages of clinical trials,” Anthony Fauci said last week.

“We are quite optimistic that by the end of this year, beginning in 2021, we will have one and maybe more, I hope, more than one vaccine will be available.”

Reuters

.



image source

Clive Palmer said hydroxychloroquine contributed to Australia’s low COVID-19 mortality rate. Is he right | Instant News


Claim

Businessman and former federal lawmaker Clive Palmer made headlines when he donated nearly 33 million doses of the anti-malaria hydroxychloroquine drug to help fight the new corona virus in Australia.

Mr. Palmer announced the prize a statement on April 23, 2020, called it “the best hope” for treating patients with COVID-19.

He also credits the drug with Australia’s low mortality rate, claiming:

Mr. Palmer repeated the claim several times over the next week, first on Sunrise, then on the full page newspaper advertisements and again during April 29 Interview with Alan Jones.

So is the use of hydroxychloroquine in the hospital the key to the low death rate of COVID-19 Australia? RMIT ABC Fact Check investigates.

Decision

Mr Palmer’s claim is baseless.

Experts consulted by Fact Check said there was no link between hydroxychloroquine and a low Australian mortality rate.

They say the death curve is flat because confirmed cases have done the same thing.

Doctors can prescribe hydroxychloroquine for Australian hospital patients with COVID-19 before 2 April.

However, since March 24 the national drug regulator has been “very unenthusiastic” in doing so unless the hospital patient is part of a clinical trial or is seriously ill.

Experts say the effectiveness of the drug against COVID-19 will not be known until the results of large-scale randomized control trials are published.

However, because of the gap between reported cases and death, it will likely take several weeks for effective drugs to reduce the mortality rate.

Which curve?

Mr Palmer spoke of Australia’s death rate, which can be stated in two-way direction: case fatality or mortality rate per capita.

Case fatality rates represent mortality as a proportion of confirmed cases – meaning that if the case increases but the death does not, the rate decreases.

Catherine Bennett, chair of epidemiology at Deakin University, told Fact Check that Australia had it expanded testing in April to capture lighter cases, so it would be “meaningless” to track case fatality rates over time.

Greg Dore, who heads the Kirby Institute Viral Hepatitis Clinical Research Program, said Australia’s extensive testing was “a major factor” in why case fatality rates are low compared to countries such as Italy, Spain and the United States, whose numbers tend to lean toward sick people.

The Fact Checker assumes that the reader will understand that Palmer is talking about Australian deaths per population head.

According to the Oxford University website Our World in Data, which presents official figures collected by the European Center for Disease Prevention and Control, Australia daily death peaking around April 4 before rising in mid-April.

In May, after Mr. Palmer claimed, cumulative death also leveled up.

Can the drug be praised?

Although Palmer praised chloroquine hydroxy with a low Australian mortality rate, experts say there is no relationship between the two.

Professor Dore said the death curve “can be predicted by changes in the number of cases”.

“It is always expected that the death rate will be delayed a few weeks after the number of cases has peaked,” he said.

“We reached a peak in terms of the number of cases at the end of March.”

Professor Bennett also said the death rate was “a product of the number of infections in Australia, and the risk profile of those cases”.

The case peaked around March 25, he said, and given the average time needed for patients to succumb to the disease, “the number of daily deaths in Australia is expected to begin to decrease from the second week of April, which is precisely what happened”.

Because of the gap between curves, Professor Bennett said that if the drug had an effect, it would likely take several weeks to reflect the mortality rate.

Load

When was it approved?

Palmer ties the Australian mortality curve evenly into April 2, claiming this is when the drug will be “available” to the hospital.

In his interview, he described the date when Health Minister Greg Hunt “permitted” the drug to be used and “decided that hydroxy chloride could be used in Australian hospitals”.

The Fact Check tried to contact Mr. Palmer by telephone and e-mail looking for evidence for his claim but did not receive a response.

Hydroxychloroquine is available Approved in Australia before the pandemic to treat malaria, lupus and rheumatoid arthritis.

Doctors can also prescribe it for conditions that are not specifically approved by the Therapeutic Goods Administration, the health department’s regulatory body for medicines, in what is called “unlabeled” use.

In general advice issued in 2017, TGA the word it recommends the use of no labels only as a last resort but acknowledges that “may be clinically appropriate in some circumstances”.

The Department of Health told Fact Check that the Department of Health does not regulate clinical decisions such as individual prescription drugs.

Allen Cheng, director of infection prevention and health epidemiology at Alfred Hospital in Melbourne, told Fact Check “there is no real limitation” for prescribing hydroxy chloroquine in COVID-19 patients in the hospital before April 2.

Available, but not recommended

Hydroxychloroquine is available for use in hospitals during April, the period covered by Palmer’s claim, but that does not mean that the Government is encouraging its use in treating COVID-19.

On March 24, citing fears of shortening supplies, the TGA announced that “only certain types of specialists can prescribe hydroxy chlorine to new patients”.

“Given the limited evidence for effects on COVID-19, as well as the risk of significant side effects, TGA strongly discourages the use of hydroxychloroquine beyond current indications other than in clinical trial settings or in a controlled environment. In the care of seriously ill patients in hospital, “he said in a statement.

Setting chloroquine hydroxy tablets.
Hydroxychloroquine is an anti-malaria drug.(AP: John Locher)

On April 1, Mr. Hunt be told An Affair Now he has just spoken to “international suppliers” and “believes that we will have a significant supply of hydroxychloroquine, which will be available if doctors want to use it with patients who are hospitalized. That is the condition”.

On April 2, the Secretary of the Department of Health created a deliverance under the Therapeutic Goods Act 1989 to enable the Government to stockpile chloroquine hydrolysis.

However, the department told Fact Check that this was “not fully approved or supported for the use of drugs for COVID-19”.

Is this widely used?

Professor Dore said that for a drug to reduce the death curve, it must be very effective and widely used among patients.

But while Mr Palmer said hydroxychloroquine was closed on the death of Australia’s COVID-19, Fact Check found little evidence of widespread use.

The federal health department says it does not collect drug information received by patients.

In a written statement, NSW Health said “understand the small number of COVID-19 patients in NSW have received hydroxychloroquine as determined by each medical practitioner”.

Fact Check approached the Minister of Health Victoria but received no response.

Professor Cheng said his hospital, one of the largest in Melbourne, did not routinely prescribe drugs for COVID-19 patients and he “would be very surprised if that happened.” [given to] more than a few patients “.

Some national data on the use of hydroxychloroquine is available through hospitals surveillance study called SPRINT-SARI, Professor Cheng said, but this only included patients in intensive care.

On April 26, intensive care patients note down less than 20 percent of COVID-19 hospitalizations.

Does the medicine work?

Mr. Palmer’s claim that hydroxychloroquine helps reduce mortality by assuming this drug is effective in treating COVID-19.

But while his Palmer Foundation website refers to a number of studies on the topic, the evidence available when he stated his claim was not encouraging.

In a report published on April 14, experts from Oxford University’s Evidence-Based Medical Center criticizing five clinical trials and found none of them “support the view that hydroxychloroquine is effective in the management of even mild disease COVID-19”.

Steven Tong from the Doherty Institute, who leads Australians clinical trial for treatment of COVID-19, also published a detailed summary of the six treatment studies available before the 23 April statement by Mr Palmer.

Released on May 6, the criticism includes two more studies published before the April 29 interview by Palmer.

“The data does not provide sufficient evidence to conclude that there are clear benefits, lack of benefits or harm,” Associate Professor Tong wrote.

Professor Bennett told Fact Check that without a control trial in which people in the same risk category were prescribed or not prescribed drugs, “You can claim anything you like, but there is too much moving stuff”.

Analyzing the largest of the studies shared on Mr Palmer’s website – a case series of 1,061 patients without a control group – he said 95 percent of patients had mild or no symptoms at first, while the more serious cases represented “the numbers were too small to compare to the COVID patient care study other “.

Professor Dore told Fact Check:

Mr Palmer, too, has recognized the need to wait for the results of the trial, telling the Sunrise program: “If we have a successful trial and we don’t have medicine, what’s the point? … I want to make sure that if the Government wants to approve it, if it wants to allow it , we will have the material. “

Since then, two large scale observational studies in New York City and the state of New York have been published, each with about 1,400 COVID-19 hospital patients.

No one found hydroxychloroquine to significantly reduce the risk of death, and while both studies did not have a control group, experts said they were a strong analysis.
Main researcher: David Campbell, with Caitlin Cassidy.

[email protected]

Source

.



image source

The Bangladesh medical team said that Ivermectin with the antibiotic Doxycycline works to treat COVID-19 patients | Instant News


A Bangladesh medical team led by a senior doctor has claimed that their research on the combination of two widely used drugs has produced remarkable results in curing patients with acute symptoms of coronavirus that have created chaos worldwide and claimed the lives of more than 312,000 people in the whole world. .

Claims by the Bangladesh medical team, which includes leading doctors from the country, came amid desperate global efforts to recover the deadly corona virus.

“We got amazing results. Of the 60 COVID-19 patients, all recovered after the combination of the two drugs was applied,” said Professor Dr. Md Tarek Alam, head of the medical department at the private Bangladesh School of Medical Schools (BMCH).

A Bangladeshi medical team examined their research on a combination of two drugs which are widely used to cure patients with symptoms of acute coronavirus.

Alam, a well-known doctor in Bangladesh, says a commonly used antiprotozoal drug called Ivermectin in a single dose with Doxycycline, an antibiotic, produces almost miraculous results in curing patients with COVID-19.

My team prescribed two drugs only for coronavirus patients, most of whom initially reported respiratory problems with related complaints, then tested COVID-19 positive, he said.

Bangladesh has reported 20,995 cases of corona virus so far. A total of 314 people have lost their lives in the country due to this disease.

Claiming that the efficacy of the drug developed by them is such that patients recover from the virus within 4 days, he said, adding that there were no side effects from it.

We first asked them to be tested for COVID-19 and when a positive coronavirus was found, we used these drugs. . . they recover in four days “.

“Repeated or second tests, according to the procedure, reconfirm their COVID-19 negative in all cases under the study which found the combination had no side effects in patients as well,” he said.

We are one hundred percent hopeful of the effectiveness of the combination, he said, adding that they have now contacted relevant government regulators and are preparing to issue international procedures for drug recognition for the treatment of COVID-19.

Alam said his team was preparing papers on drug development for international journals, as needed for scientific review and recognition.

Nature’s colleague, Dr. Rabiul Morshed, said that despite being a non-COVID-19 facility, a large number of patients, directly and indirectly, ended up at BMCH, the country’s main private public hospital.

But all showed remarkable recovery (COVID-19) negative in four days and 50 percent reduction in symptoms in three days, he said.

Coronavirus, which originally erupted in China, claimed the lives of 312,115 people while infecting more than 4,650,793, according to Johns Hopkins University.

Updated Date: May 19, 2020 09:21:13 IST

Tag:

Antibiotics,

Antiprotozoal,

Corona virus,

Coronavirus case,

Corona virus lockout,

Corona virus treatment,

Cure,

Death Case,

Doxycycline,

Drugs,

Frontline Workers,

Increased Coronavirus Cases,

Ivermectin,

Pandemic,

Treatment,

Vaccine,

WHO

.



image source

Coronavirus can spread through sexual contact because traces are found in semen | Instant News


Chinese researchers who tested the sperm of men infected with COVID-19 found that a small proportion of them had a new corona virus in their semen, opening the likelihood of the disease being sexually transmitted, scientists said Thursday.

A study by doctors at 38 hospitals in Shangqiu city in China who were hospitalized with this disease found that six of them, or 16 percent, tested positive for SARS-CoV-2 in their semen.

The researchers said that while the findings were only temporary and were only based on a small number of infected men, further research was needed to see whether sexual transmission might play a role in the spread of the COVID-19 pandemic.

The corona virus has been declared a pandemic by WHO.
A study has found that the virus that causes COVID-19 is detected in the sperm of several infected male patients. Image credit: Pixabay

“Further research is needed regarding detailed information about virus release, survival time, and concentration in semen,” the team wrote in a study published on JAMA Network Open.

“If it can be proven that SARS-CoV-2 can be transmitted sexually … (it) may be an important part of prevention,” they said, “especially given the fact that SARS-CoV-2 was detected in semen of recovered patients.”

Independent experts say the findings are interesting but must be viewed with caution and in the context of other small studies that have not yet found new coronaviruses in sperm.

An earlier small study of 12 COVID-19 patients in China in February and March found that all were tested negative for SARS-CoV-2 in semen samples.

Allan Pacey, a professor of andrology at the University of Sheffield in England, said the study should not be seen conclusively because there are some technical difficulties in testing semen for the virus. He said the presence of SARS-CoV-2 in sperm did not indicate whether it was active and capable of causing infection.

“However, we should not be surprised if the virus that causes COVID-19 is found in the semen of some men because this has been demonstrated with many other viruses such as Ebola and Zika,” he said.

Sheena Lewis, a professor of reproductive medicine at Queen’s University Belfast, stressed that this was a “very small study” and said her findings were consistent with other small studies that showed low or no SARS-CoV-2 in semen sample tests.

“However, the long-term effects of SARS-CoV-2 on male reproduction are unknown,” he said.

Updated Date: May 11, 2020 16:32:20 IST

Tag:

Corona virus,

Coronavirus case,

Corona virus lockout,

Coronavirus epidemic,

Coronavirus Testing,

Cure,

Death Case,

Reducing the Locking Restriction,

Frontline Workers,

Increased Coronavirus Cases,

Infected Men,

Pandemic,

Semen,

Treatment,

Vaccine,

WHO

.



image source